XML 56 R47.htm IDEA: XBRL DOCUMENT v3.22.4
NOTE 12 - SEGMENT INFORMATION: Schedule of Segment Income (Tables)
6 Months Ended
Oct. 31, 2022
Tables/Schedules  
Schedule of Segment Income

 

Three Months Ended October 31,

Six Months Ended October 31,

 

2022

 2021

2022

2021

Revenues:

 

 

 

 

Stevioside

$7,305,077 

$10,001,477 

 $ 14,912,400

$16,163,155 

Corporate and other

  98,185

106,647 

200,765 

213,429 

Total segment and consolidated revenues

$7,403,262 

$10,108,124 

$15,113,165 

$16,376,584 

Interest expense:

 

 

 

 

Stevioside

$(124,622) 

$(119,934) 

$(257,643) 

$(190,605) 

Corporate and other

 

 

 

 

Total segment and consolidated interest expense

$(124,622) 

$(119,934) 

$(257,643) 

$(190,605) 

Depreciation and amortization:

 

 

 

 

Stevioside

$281,571 

$312,038  

$573,745 

$623,881  

Corporate and other

  37,537

56,349  

77,891 

112,942  

Total segment and consolidated depreciation and amortization

 $ 319,108

$368,387  

 $ 651,636

$736,823   

Income (loss) from operations before income taxes:

 

 

 

 

Stevioside

$(318,921) 

$(1,941,725) 

$(573,852) 

$(2,753,962) 

Corporate and other

59,270  

48,952  

120,050  

111,072  

Total loss from operations before income taxes

$(259,651) 

$(1,892,773) 

$(453,802) 

$(2,642,890)